Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents

  • Nickoloff B
  • Osborne B
  • Miele L
  • 97


    Mendeley users who have this article in their library.
  • 242


    Citations of this article.


Notch signaling controls cell fate decisions including during development and stem cell renewal and differentiation in many postnatal tissues. Increasing evidence suggests that the Notch signaling network is frequently deregulated in human malignancies and that genetic or pharmacological manipulation of Notch signaling is a novel potential strategy for the treatment of human neoplasms. This review article summarizes the most recent preclinical and clinical evidence linking Notch signaling to cancer, delineates questions that remain unanswered and explores potential biopharmacological strategies to manipulate Notch signaling in vivo.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Brian J Nickoloff

  • Barbara A Osborne

  • Lucio Miele

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free